Skip to main content
. 2023 Dec 1;14:7762. doi: 10.1038/s41467-023-43498-3

Fig. 3. Identification of patients-specific MYC enhancer-ome in different MRT PDOs.

Fig. 3

A Contact map of 4C-seq data identifies chromatin interactions between the MYC promoter and three Rhabdoid Oncogenic MYC Enhancers (RhOMEs) in two additional MRT PDO models (P60 and P78; n = 2). B Chromatin accessibility and (C) enhancer RNA (eRNA) expression at the three RhOMEs and the MYC mRNA expression in the indicated MRT PDOs with (SMARCB1 + ) and without (Control) SMARCB1 expression.